When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 19 Mar 2025
Last updated: 16 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • rapid onset of signs and symptoms (acute septic CST)
  • headache
  • fever
  • peri-orbital oedema
  • chemosis and proptosis
  • lateral gaze palsy
  • ophthalmoplegia
  • profound sepsis (acute septic CST)

Other diagnostic factors

  • ptosis and mydriasis
  • papilloedema and/or retinal-vein dilatation
  • decreased corneal reflex
  • hypo- or hyper-aesthesia in the distribution of the ophthalmic and maxillary nerves
  • mental state changes (e.g., confusion, drowsiness, coma)
  • clinically detectable primary infection site
  • meningismus (nuchal rigidity, photophobia, and headache)
  • positive Kernig's or Brudzinski's signs
  • seizures
  • loss of visual acuity

Risk factors

  • recent history of acute sinusitis
  • history of facial infections
  • history of peri-orbital infection
  • history of otitis media, mastoiditis, or petrositis
  • history of dental or oral infection
  • history of sepsis
  • immunosuppression
  • genetic prothrombotic condition
  • acquired and other prothrombotic states
  • history of head and neck trauma
  • use of oral contraceptives
  • pregnant or postpartum
  • history of malignancy
  • history of recent head or neck surgery
  • vascular abnormalities
  • ulcerative colitis
  • volume depletion
  • heroin overdose

Diagnostic investigations

1st investigations to order

  • FBC
  • contrast-enhanced high-resolution CT of head
  • contrast-enhanced MRI of head
  • blood culture
  • microscopy and culture of suppurative fluid or tissue from primary infective source
  • antiphospholid and anticardiolipin antibodies
  • protein S and protein C
  • antithrombin III
  • factor V Leiden
  • haemoglobin electrophoresis

Investigations to consider

  • lumbar puncture with cerebrospinal fluid analysis

Treatment algorithm

Contributors

Authors

Jayant Pinto, MD

Associate Professor of Surgery

Section of Otolaryngology-Head and Neck Surgery

University of Chicago

IL

Disclosures

JP serves as a speaker and advisor to Optinose and Stallergenes. JP is a member of the advisory board for Genentech and ALK. JP has received grants from the National Institutes of Health.

Mohamad R. Chaaban, MD, MSCR, MBA

Associate Professor

Cleveland Clinic

Lerner College of Medicine at Case Western Reserve University

Cleveland

OH

Disclosures

MC is a member of the advisory board of Optinose.

Peer reviewers

David Rowed, MD

Division of Neurosurgery

University of Toronto

Toronto

Ontario

Canada

Disclosures

DR declares that he has no competing interests.

Louis R. Caplan, MD

Lecturer in Neurology

Hospital Chief

Cerebrovascular/Stroke Division

Beth Israel Deaconess Medical Center

Division of Cerebrovascular/Stroke

Boston

MA

Disclosures

LRC declares that he has no competing interests.

Sorabh Khandelwal, MD

Clinical Associate Professor of Emergency Medicine

Ohio State University

Columbus

OH

Disclosures

SK declares that he has no competing interests.

Use of this content is subject to our disclaimer